Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01473888 · ClinicalTrials.gov registry record · Phase 1
A Study To Evaluate The Effect of T89(Dantonic®)On P450 Enzymes
A Phase 1 study, sponsored by Tasly Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT01473888 is a Phase 1 study that has completed, run by Tasly Pharmaceuticals. The registered enrollment target is 24 participants.
The verdict
NCT01473888, a Phase 1 study, has completed, sponsored by Tasly Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
Purpose: This study is to determine the effect of T89(Dantonic®)on P450 enzymes. This study will help determine which types of drugs may interact with T89.
Interventions
- DRUG T89(Dantonic)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2011-01 |
| Est. Completion | 2012-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01473888
The ClinicalTrials.gov registry entry for NCT01473888 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tasly Pharmaceuticals, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which T89(Dantonic) is the first listed.
NCT01473888 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01473888 about?
NCT01473888 is a clinical study titled "A Study To Evaluate The Effect of T89(Dantonic®)On P450 Enzymes". Purpose: This study is to determine the effect of T89(Dantonic®)on P450 enzymes. This study will help determine which types of drugs may interact with T89.
What is the current status of trial NCT01473888?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2011-01. Estimated completion is 2012-01.
What interventions are being tested in trial NCT01473888?
The interventions under investigation include: T89(Dantonic) (DRUG).
Who is sponsoring clinical trial NCT01473888?
This trial is sponsored by Tasly Pharmaceuticals, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.